Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Regulatory T-cell remodeling across the HBV infection–cirrhosis continuum
Frontiers in Immunology
September 2026
Fu Y.
Open Access
Study of the Molecular Dynamics Stability in the Inhibitory Interaction of Tenofovir Disoproxil Fumarate against CTLA-4 in Chronic Hepatitis B Patients
Medical Archives
2023
Darmadi D.
All Open Access, Green
Cytokines and Chemokines in HBV Infection
Frontiers in Molecular Biosciences
2 December 2021
Zhong S.
Open Access
Changes of cytokine levels and T cell surface molecules in patients with chronic hepatitis B and the association with functional cure
Journal of Medical Virology
August 2021
Xu Z.
FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B
Future Virology
April 2020
Cho H.
The effects of nucleoside/nucleotide analogues on host immune cells: The baseline for future immune therapy for HBV?
Antiviral Therapy
2020
Boeijen L.L.
Role of immune cells in hepatitis B infection
Dynamics of Immune Activation in Viral Diseases
1 January 2020
Sinha P.
Interleukin-35 modulates the balance between viral specific CD4 + CD25 + CD127 dim/- regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
Virology Journal
16 April 2019
Yang L.
Open Access
The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics
Journal of Viral Hepatitis
January 2019
Gill U.S.
The effect of entecavir therapy on immune status in chronic hepatitis B patients
Iranian Journal of Immunology
2019
Yan H.
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study
Journal of Hepatology
June 2018
Zhu S.
Current concepts on immunopathogenesis of hepatitis B virus infection
Virus Research
2 February 2018
Peeridogaheh H.
Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment
Medicine United States
1 June 2017
Yang X.
Open Access
Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment
Scientific Reports
15 November 2016
Guo R.
Open Access
Th17/Treg cell expression in children with primary nephritic syndrome and the effects of ox-LDL on Th17/Treg cells
Genetics and Molecular Research
10 June 2016
Li Y.Y.
Open Access
Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B
Annals of Hepatology
March-April 2016
Zhan-Fei T.
Role of Tim-3 in hepatitis B virus infection: An overview
World Journal of Gastroenterology
21 February 2016
Liu Y.
Open Access
Association of expression of peripheral CD4+CD25+CD127low/- regulatory T cells with liver pathology and HBV-cccDNA in patients with chronic hepatitis B
Journal of Xi an Jiaotong University Medical Sciences
January 2016
Chao P.P.
Sustained Changes of Treg and Th17 Cells during Interferon-α Therapy in Patients with Chronic Hepatitis B
Viral Immunology
1 October 2015
Feng H.
Long-term treatment of HBV infection with oral polymerase inhibitors
Gastroenterologe
30 July 2015
van Bömmel F.
Toll-like receptor 2 promotes T helper 17 cells response in hepatitis B virus infection
International Journal of Clinical and Experimental Medicine
2015
Zhao R.R.
The influences of antiviral therapy on T-cell function in adult patients with chronic hepatitis B
Future Virology
1 October 2014
Harkisoen S.
Advances in understanding relationship between peripheral blood CD4+CD25+ regulatory T cells and antiviral treatment in CHB patients
World Chinese Journal of Digestology
2014
Pan Z.Q.
Open Access